Healthcare -
Biotechnology - NASDAQ - US
$ 4.14
-2.62 %
$ 178 M
Market Cap
-6.39
P/E
DMAC - CASH FROM OPERATIONS
Cash from Operations DMAC - DiaMedica Therapeutics Inc.
-22.1 M
LAST VALUE
-38.49%
2 YEAR CAGR
-19.39%
5 YEAR CAGR
-19.38%
10 YEAR CAGR